Stock Events

Stock Events

Dexcom 

€50.8
522
-€0.6-1.17% Tuesday 19:46

Statistics

Day High
51.8
Day Low
50.4
52W High
78.36
52W Low
47.35
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q4 2025
Q1 2026
Next
0.4
0.46
0.51
0.57
Expected EPS
0.51592289823
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DC4.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories competes with Dexcom in the continuous glucose monitoring (CGM) market, particularly with their FreeStyle Libre system.
Medtronic
MDT
Mkt Cap102.71B
Medtronic is a direct competitor in the CGM and diabetes management market, offering products like the Guardian Connect system.
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Tandem Diabetes Care partners with Dexcom for CGM integration but also competes in providing comprehensive diabetes management solutions.
Insulet
PODD
Mkt Cap12.12B
Insulet Corporation's Omnipod system is a competitor in the broader diabetes management space, offering an alternative to traditional insulin delivery and monitoring systems.
Senseonics
SENS
Mkt Cap213.2M
Senseonics Holdings offers the Eversense CGM system, providing long-term implantable glucose monitoring, a direct competitor to Dexcom's wearable CGM products.
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk competes indirectly through their extensive range of diabetes care products, including insulin and non-insulin treatments, which are part of integrated diabetes management.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes in the diabetes market with its insulin and glucose monitoring solutions, offering an alternative to Dexcom's CGM systems.
Mckesson
MCK
Mkt Cap99.71B
McKesson Corporation, through its distribution of diabetes care products including CGMs, competes in the broader market for diabetes management solutions.
Cardinal Health
CAH
Mkt Cap45.94B
Cardinal Health is involved in the distribution of various healthcare products, including diabetes care supplies, competing in the broader market for diabetes management.

About

There is no Profile data available for DC4.MU.
Show more...
CEO
Country
United States
ISIN
US2521311074

Listings

STU
DE
DC4.STU
MU
DE
DC4.MU
MI
IT
1DXCM.MI
XETRA
DE
DC4.XETRA

0 Comments

Share your thoughts

FAQ

What is Dexcom stock price today?▼
The current price of DC4.STU is €50.8 EUR — it has decreased by -1.17% in the past 24 hours. Watch Dexcom stock price performance more closely on the chart.
What is Dexcom stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dexcom stocks are traded under the ticker DC4.STU.
Is Dexcom stock price growing?▼
DC4.STU stock has risen by +3.25% compared to the previous week, the month change is a -5.65% fall, over the last year Dexcom has showed a -29.48% decrease.
When is the next Dexcom earnings date?▼
Dexcom is going to release the next earnings report on July 23, 2026.
What were Dexcom earnings last quarter?▼
DC4.STU earnings for the last quarter are 0.48 EUR per share, whereas the estimation was 0.4 EUR resulting in a +20.27% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is Dexcom located?▼
Dexcom operates in the Other sector.
When did Dexcom complete a stock split?▼
Dexcom has not had any recent stock splits.